Enveric Biosciences, Inc.
Enveric Biosciences, Inc. (ENVB): 2 pipeline candidates. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
0% dilution
Lead: Preclinical
2 candidates
N/A
N/A
A transparent, data-derived signal for Enveric Biosciences, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$5.6M
Cash
—
Quarterly Burn
$2.3M
Runway
—
Revenue
—
Pipeline (2 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$97K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 32,149 | $62K |
| advisorshares investments llc | 16,974 | $33K |
| jones financial companies lllp | 1,000 | $2K |
| blackrock, inc. | 51 | $99 |
| danske bank a/s | 1 | $2 |
| group one trading llc | 1 | $2 |
| national bank of canada /fi/ | 1 | $2 |
| wells fargo & company/mn | 1 | $2 |
Frequently asked questions
How many drug candidates are in Enveric Biosciences, Inc.'s pipeline?
Enveric Biosciences, Inc. (ENVB) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Enveric Biosciences, Inc.'s lead drug candidate?
Enveric Biosciences, Inc.'s most advanced tracked candidate is eb-002 (Preclinical) for Neuropsychiatric disorders.
What is Enveric Biosciences, Inc.'s market capitalization?
Enveric Biosciences, Inc.'s market capitalization is approximately $5.6M.
Who is the CEO of Enveric Biosciences, Inc.?
Dr. Joseph Edward Tucker Ph.D. is the chief executive officer of Enveric Biosciences, Inc. (ENVB).
Get the full picture on Enveric Biosciences, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.